CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Current Portion of Long-Term Debt
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) had Current Portion of Long-Term Debt of $5.46 million as of 2026-06-27, per its 10-Q filed 2026-08-05.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Long-Term Debt and Lease Obligation, Current
us-gaap:LongTermDebtCurrent · last filed 2026-08-05
- 2026-06-27: Long-term Debt, Current Maturities $5.46M.
- 2026-03-28: Long-term Debt, Current Maturities $6.70M.
- 2025-12-27: Long-term Debt, Current Maturities $166.00K.
- 2025-09-27: Long-term Debt, Current Maturities $54.00K.
| Period end | Long-term Debt, Current Maturities | Long-term Debt, Current Maturities as first filed |
|---|---|---|
| 2026-06-27 | $5.46M 10-Q · filed 2026-08-05 | |
| 2026-03-28 | $6.70M 10-Q · filed 2026-05-07 | |
| 2025-12-27 | $166.00K 10-Q · filed 2026-08-05 | |
| 2025-09-27 | $54.00K 10-Q · filed 2025-11-05 | |
| 2025-06-28 | $98.00K 10-Q · filed 2025-08-06 | |
| 2025-03-29 | $121.00K 10-Q · filed 2025-05-07 | |
| 2024-12-28 | $155.00K 10-K · filed 2026-02-18 | |
| 2024-09-28 | $157.00K 10-Q · filed 2024-11-06 | |
| 2024-06-29 | $435.00K 10-Q · filed 2024-08-07 | |
| 2024-03-30 | $459.00K 10-Q · filed 2024-05-09 | |
| 2023-12-30 | $3.17M 10-K · filed 2025-02-19 | |
| 2023-09-30 | $797.00K 10-Q · filed 2023-11-08 | |
| 2023-07-01 | $1.19M 10-Q · filed 2023-08-09 | |
| 2023-04-01 | $4.00M 10-Q · filed 2023-05-11 | |
| 2022-12-31 | $1.35M 10-K · filed 2024-02-14 | |
| 2022-09-24 | $0.00 10-Q · filed 2022-11-02 | |
| 2022-06-25 | $95.00K 10-Q · filed 2022-08-03 | |
| 2022-03-26 | $99.00K 10-Q · filed 2022-05-04 | |
| 2021-12-25 | $101.00K 10-K · filed 2023-02-22 | |
| 2021-09-25 | $105.00K 10-Q · filed 2021-11-03 | |
| 2021-06-26 | $108.00K 10-Q · filed 2021-08-04 | |
| 2021-03-27 | $109.00K 10-Q · filed 2021-05-04 | |
| 2020-12-26 | $47.20M 10-K · filed 2022-02-16 | |
| 2020-09-26 | $45.02M 10-Q · filed 2020-10-29 | |
| 2020-06-27 | $50.51M 10-Q · filed 2020-08-05 | |
| 2020-03-28 | $44.74M 10-Q · filed 2020-05-07 | |
| 2019-12-28 | $35.55M 10-K · filed 2021-02-17 | |
| 2019-09-28 | $30.61M 10-Q · filed 2019-11-06 | |
| 2019-06-29 | $30.71M 10-Q · filed 2019-07-31 | |
| 2019-03-30 | $28.23M 10-Q · filed 2019-05-07 | |
| 2018-12-29 | $28.23M 10-K · filed 2020-02-11 | |
| 2018-09-29 | $28.23M 10-Q · filed 2018-11-07 | |
| 2018-06-30 | $28.23M 10-Q · filed 2018-08-08 | |
| 2018-03-31 | $111.00K 10-Q · filed 2018-05-10 | |
| 2017-12-30 | $28.55M 10-K · filed 2019-02-13 | |
| 2017-09-30 | $24.48M 10-Q · filed 2017-11-09 | |
| 2017-07-01 | $24.58M 10-Q · filed 2017-08-09 | |
| 2017-04-01 | $24.56M 10-Q · filed 2017-05-10 | |
| 2016-12-31 | $24.56M 10-K · filed 2018-02-13 | |
| 2016-09-24 | $24.57M 10-Q · filed 2016-11-02 | |
| 2016-06-25 | $32.70M 10-Q · filed 2016-08-03 | |
| 2016-03-26 | $20.20M 10-Q · filed 2016-05-04 | |
| 2015-12-26 | $15.19M 10-K · filed 2017-02-14 | |
| 2015-09-26 | $15.20M 10-Q · filed 2015-11-04 | |
| 2015-06-27 | $15.20M 10-Q · filed 2015-07-30 | |
| 2015-03-28 | $31.70M 10-Q · filed 2015-04-30 | |
| 2014-12-27 | $31.71M 10-K · filed 2016-02-12 | |
| 2014-09-27 | $31.72M 10-Q · filed 2014-10-30 | |
| 2014-06-28 | $31.74M 10-Q · filed 2014-08-07 | |
| 2014-03-29 | $26.49M 10-Q · filed 2014-04-30 | |
| 2013-12-28 | $21.24M 10-K · filed 2015-02-17 | |
| 2013-09-28 | $15.99M 10-Q · filed 2013-10-30 | |
| 2013-06-29 | $15.98M 10-Q · filed 2013-07-31 | |
| 2013-03-30 | $130.66M 10-Q · filed 2013-05-08 | |
| 2012-12-29 | $139.37M 10-K · filed 2014-02-25 | -$139.37M 10-K · filed 2013-02-27 |
| 2012-09-29 | $125.59M 10-Q · filed 2012-11-01 | |
| 2012-06-30 | $134.81M 10-Q · filed 2012-08-07 | |
| 2012-03-31 | $29.55M 10-Q · filed 2012-05-04 | |
| 2011-12-31 | $14.73M 10-K · filed 2013-02-27 | |
| 2010-12-25 | $30.54M 10-K · filed 2012-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |